Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
50
PharmaCompass offers a list of Spectinomycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Spectinomycin manufacturer or Spectinomycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Spectinomycin manufacturer or Spectinomycin supplier.
PharmaCompass also assists you with knowing the Spectinomycin API Price utilized in the formulation of products. Spectinomycin API Price is not always fixed or binding as the Spectinomycin Price is obtained through a variety of data sources. The Spectinomycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Spectinomycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spectinomycin, including repackagers and relabelers. The FDA regulates Spectinomycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spectinomycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Spectinomycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Spectinomycin supplier is an individual or a company that provides Spectinomycin active pharmaceutical ingredient (API) or Spectinomycin finished formulations upon request. The Spectinomycin suppliers may include Spectinomycin API manufacturers, exporters, distributors and traders.
click here to find a list of Spectinomycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Spectinomycin DMF (Drug Master File) is a document detailing the whole manufacturing process of Spectinomycin active pharmaceutical ingredient (API) in detail. Different forms of Spectinomycin DMFs exist exist since differing nations have different regulations, such as Spectinomycin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Spectinomycin DMF submitted to regulatory agencies in the US is known as a USDMF. Spectinomycin USDMF includes data on Spectinomycin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Spectinomycin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Spectinomycin suppliers with USDMF on PharmaCompass.
A Spectinomycin CEP of the European Pharmacopoeia monograph is often referred to as a Spectinomycin Certificate of Suitability (COS). The purpose of a Spectinomycin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Spectinomycin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Spectinomycin to their clients by showing that a Spectinomycin CEP has been issued for it. The manufacturer submits a Spectinomycin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Spectinomycin CEP holder for the record. Additionally, the data presented in the Spectinomycin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Spectinomycin DMF.
A Spectinomycin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Spectinomycin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Spectinomycin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Spectinomycin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Spectinomycin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Spectinomycin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Spectinomycin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Spectinomycin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Spectinomycin suppliers with NDC on PharmaCompass.
Spectinomycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Spectinomycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Spectinomycin GMP manufacturer or Spectinomycin GMP API supplier for your needs.
A Spectinomycin CoA (Certificate of Analysis) is a formal document that attests to Spectinomycin's compliance with Spectinomycin specifications and serves as a tool for batch-level quality control.
Spectinomycin CoA mostly includes findings from lab analyses of a specific batch. For each Spectinomycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Spectinomycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Spectinomycin EP), Spectinomycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spectinomycin USP).
